Morning Market Roundup : 22 June 2020

-Glenmark drug FabiFlu for mild Covid patients hits market. 80% patients are mildly sick, priced at Rs 103 a pill.

-FIIs net bought shares worth Rs. 1,237 cr, DIIs net sold shares worth Rs 881 cr in the Indian equity market on June 19.

-Finance Ministry proposes restriction on Foreign Investment in Pension funds from China.

-Area under Kharif Crops surpasses last year by 39% as Monsoon Progresses.

-People bank of China sets rate unchengef 1 year rate at 3.85% and 5 year 4.65%.

-UK to further ease coronavirus lockdown restrictions on Tuesday.

-The Indian market ended the week ended June 19 on a positive note as the equity benchmarks Sensex and Nifty rose almost 3 percent week-on-week.

-PMO seeks product-wise details to curb china imports. 

-Petrol & Diesel prices increase on 15th day in a row, cumulative increased by Rs. 8.88 and 7.97 in petrol and diesel respectively. 

-The RBI lending institutions should assign zero per cent risk weight on the credit facilities extended under the Emergency Credit for MSME. 

-China announcend tariff exemption for 97 percent of Bangladeshi products effective from July 1.

-Results on June 22

Aegis Logistics, AIA Engineering, Balaji Amines, Dhanlaxmi Bank, Kirloskar Industries, Morepen Laboratories, OnMobile Global, Skipper, Sudarshan Chemical Industries, The Investment Trust Of India, UFO Moviez.